Skip to main content

Dan German Blazer III, MD

Publications

Tsai, Catherine, Alexandra Mueller, Johannes Maubach, Rene Warschkow, Daniel P. Nussbaum, Bruno M. Schmied, Dan Blazer, Beat Gloor, and Mathias Worni. “No Difference in Survival between Neo-Adjuvant Chemotherapy and Neo-Adjuvant Chemoradiation Therapy in Gastric Cardia Cancer Patients: A Contemporary View from the National Cancer Database.” Dig Surg 37, no. 3 (2020): 249–57. https://doi.org/10.1159/000501678.

Full Text

VanDusen, Keith W., Sarada Eleswarpu, Eugene W. Moretti, Michael J. Devinney, Donna M. Crabtree, Daniel T. Laskowitz, Marty G. Woldorff, et al. “The MARBLE Study Protocol: Modulating ApoE Signaling to Reduce Brain Inflammation, DeLirium, and PostopErative Cognitive Dysfunction.” J Alzheimers Dis 75, no. 4 (2020): 1319–28. https://doi.org/10.3233/JAD-191185.

Full Text

Kerr, David L., Brian L. Dial, Alexander L. Lazarides, Anthony A. Catanzano, Whitney O. Lane, Dan G. Blazer, Brian E. Brigman, Sergio Mendoza-Lattes, William C. Eward, and Melissa E. Erickson. “Epidemiologic and survival trends in adult primary bone tumors of the spine.” Spine J 19, no. 12 (December 2019): 1941–49. https://doi.org/10.1016/j.spinee.2019.07.003.

Full Text

Elizabeth McCracken, Emily K., Gregory P. Samsa, Deborah A. Fisher, Norma E. Farrow, Karenia Landa, Kevin N. Shah, Dan G. Blazer, and Sabino Zani. “Prognostic significance of primary tumor sidedness in patients undergoing liver resection for metastatic colorectal cancer.” Hpb (Oxford) 21, no. 12 (December 2019): 1667–75. https://doi.org/10.1016/j.hpb.2019.03.365.

Full Text

Schmitz, Robin, Mohamed A. Adam, and Dan G. Blazer. “Overcoming a travel burden to high-volume centers for treatment of retroperitoneal sarcomas is associated with improved survival.” World J Surg Oncol 17, no. 1 (November 4, 2019): 180. https://doi.org/10.1186/s12957-019-1728-z.

Full Text

Kent, C. L., D. Marin, D. Niedzwiecki, S. J. Stephens, E. Duffy, M. Malicki, J. Abbruzzese, et al. “Imaging & Biomarker Correlates on Outcomes in a Phase II Trial of Neoadjuvant Gemcitabine/Nab-Paclitaxel and Hypofractionated Image-Guided Radiotherapy (HIGRT) in Potentially Resectable Pancreas Cancer.” In International Journal of Radiation Oncology*Biology*Physics, 105:E238–39. Elsevier BV, 2019. https://doi.org/10.1016/j.ijrobp.2019.06.2014.

Full Text

Mao, Rui, Hong Zhao, Kan Li, Sheng Luo, Megan Turner, Jian-Qiang Cai, and Dan Blazer. “Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database.” Ann Surg Oncol 26, no. 9 (September 2019): 2722–29. https://doi.org/10.1245/s10434-019-07506-5.

Full Text

Turner, M. C., D. Becerra, Z. Sun, J. Watson, K. Leung, J. Migaly, C. R. Mantyh, and D. G. Blazer. “The side of the primary tumor affects overall survival in colon adenocarcinoma: an analysis of the national cancer database.” Tech Coloproctol 23, no. 6 (June 2019): 537–44. https://doi.org/10.1007/s10151-019-01997-w.

Full Text

Landa, Karenia, Kyle Freischlag, Daniel P. Nussbaum, Linda M. Youngwirth, and Dan G. Blazer. “Underutilization of surgical resection in patients with pancreatic acinar cell carcinoma.” Hpb (Oxford) 21, no. 6 (June 2019): 687–94. https://doi.org/10.1016/j.hpb.2018.10.014.

Full Text

Pages